Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia

BACKGROUND: Development of precision medicine requires the identification of easily detectable and druggable biomarkers. Despite recent targeted drug approvals, prognosis of acute myeloid leukemia (AML) patients needs to be greatly improved, as relapse and refractory disease are still difficult to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuesta-Casanovas, Laia, Delgado-Martínez, Jennifer, Cornet-Masana, Josep M., Carbó, José M., Banús-Mulet, Antònia, Guijarro, Francesca, Esteve, Jordi, Risueño, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197460/
https://www.ncbi.nlm.nih.gov/pubmed/37208719
http://dx.doi.org/10.1186/s12935-023-02944-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197460/
https://www.ncbi.nlm.nih.gov/pubmed/37208719
http://dx.doi.org/10.1186/s12935-023-02944-4

Ejemplares similares